20% Solcoseryl gel 5g eye

  • $14.90
Out Of Stock
Sku: 1128a919d004
The instruction for medical use

of SOLKOSERIL medicine

the Trade name

Mezhdunarodnoye the unlicensed name
Is not present

the Dosage form
Gel of eye, 5 g

1 g of gel contains
active agent - deproteined hemoderivative from blood of milk calfs (Bos Taurus) standardized chemically and biologically 8.3 mg,
excipients - a benzalkoniya chloride, sodium carboxymethylcellulose, edetat sodium a dihydrate, sorbitol of 70%, water for injections, solution of sodium of hydroxide of 27% (for adjustment rn).

The description
From colourless till slightly yellowish color poorly opalescent fluid gel, almost flavourless

Pharmacotherapeutic group
Drugs for treatment of diseases of eyes
Drugs for treatment of diseases of eyes other
the ATX S01XA Code

the Pharmacological

Pharmacokinetics As well as properties in a case with other biologically standardized drugs, absorption, distribution and elimination of active component of the drug Solkoseril eye gel - deproteined hemoderivative cannot be studied by usual pharmacokinetic methods. Besides, deproteined hemoderivative of blood of milk calfs contains low-molecular components of serum and blood cells in the structure, it is normal of attendees in an organism.
The pharmacodynamics
Active component of the drug Solkoseril represents eye gel chemically and biologically standardized deproteined hemoderivative received from blood of milk calfs (Bos Taurus) by dialysis and ultrafiltration (nominal size 5000 Yes). Solkoseril contains a large number of the low-molecular components received from cells and blood serum of milk calfs: electrolytes, amino acids, nucleotides, nucleosides, oligopeptida and intermediate products carbohydrate and lipometabolism. Clinical performance of drug is caused by synergism of all Solkoserila components. Established that Solkoseril:
- supports and restores the processes of aerobic metabolism and oxidizing phosphorylation, filling shortage of high-energy phosphates in cells, improves utilization of oxygen and accelerates glucose transport in metabolic exhausted fabrics and cells subject to a hypoxia,
- accelerates processes of regeneration of the damaged and/or exhausted fabrics,
- warns or reduces risk of emergence of a secondary degeneration and pathological changes in reversibly the damaged cells,
- accelerates processes of synthesis of collagen and stimulates processes of proliferation and migration in cells.
Solkoseril eye gel protects fabrics from a hypoxia and/or nutrient deficiency, promotes restoration of normal functioning of fabrics with reversible damages and accelerates process of healing of damages, at the same time improving quality of healing. Solkoseril eye gel is the dosage form developed especially for treatment of defeats of a cornea and a conjunctiva as it promotes angenesis and reduces risk of formation of hems. Thanks to the gel consistence caused by presence at composition of drug of sodium salt of carboxymethylcellulose, Solkoseril has good adhesive properties and provides a uniform and long-term covering of a cornea and a conjunctiva owing to what active agent continuously gets into the struck fabric.

of Adyyuvantnaya therapy in complex treatment:
- helcomas of various origin
- damages of a cornea
- the burns of a cornea caused by alkalis or acids
- degenerative changes of a cornea and conjunctiva
- a bullous keratitis
the Route of administration and doses
to Adults and children are more senior than 8 years to dig in 3-4 times a day on 1 drop of eye gel in a conjunctival sac.

- short-term weak burning (that is not the reason for drug withdrawal)
- allergic reactions, occasionally at reuse

of the Contraindication
- hypersensitivity to drug components
- children up to 8 years

Medicinal interactions
At simultaneous use of several ophthalmologic drugs it is necessary to dig in eye gel not earlier than in 15 minutes after use of other medicine.
Eye gel the efficiency of locally applied antinukleozidny virostatik, such as Acyclovir or Idoksuridin can reduce natural metabolites of the drug Solkoseril.

Special instructions
When burying it is not necessary to touch a tube tip fingers. It is recommended to close a tube at once after drug use.
During the Solkoseril drug treatment eye gel it is necessary to refrain from carrying contact lenses, owing to sticking of gel to a surface of contact lenses.
In case of infection of an eye Solkoseril is not recommended to apply eye gel as the only medicine.
Use of drug in pediatrics
Use of drug for treatment of children is more senior than 8 years perhaps on doctor's orders.
Pregnancy and the period of a lactation
Clinical trials of Solkoseril of eye gel at pregnancy and in the period of a lactation were not carried out. Use of drug for treatment of pregnant women and the feeding women perhaps on doctor's orders if the expected advantage exceeds risk for a fruit and the child.
The feature of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms
Due to the temporary decrease in clearness of visual perception within 20 min. after use of eye gel to patients should abstain from occupations potentially dangerous types of activity (driving of the car, work with mechanisms, etc.).

The overdose
is not revealed
the Form of release and packing
On 5 g of drug place in tubas aluminum with the applicator and the screw-on cap.
On 1 tuba together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.

To Store storage conditions at a temperature not above 25 °C.
To store out of children's reach!

A period of storage
3 years
the use Period after opening of a tuba – 4 weeks, at a temperature not above 25 °C.
Not to apply after an expiration date.

Prescription status
According to the prescription

the Producer
of Legasi Pharmasyyutikals Switzerland Ryurbergstrasse
21, 4127 GmbH Birsfelden, Switzerland

the Owner of the registration certificate
of MEDA Pharm GmbH, Austria

the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products
Representation Pharmasyyutikalz HONEY Switzerland GmbH in the Republic of Kazakhstan: Almaty, Dostyk Ave. 97, office 8, ph. 264-17-94, ph./fax 264-17-71
E-mail address: info.safety@meda-cis.com
Write a review
Related Products
Lecos (Kazakhstan)
Allergostop 4% Eye Drops 10 ml.
S.C. Rompharm Company S.R.L. (Romania)
Tsirelaks 5 ml 1% eye drops
Santen (Finland)
Lekrolin 4% (40 mg / ml) 5 ml of eye drops
Jamjoom Pharmaceuticals Co. Ltd (Saudi Arabia)
Brimo 5 ml of eye drops
Alcon (Belgium)
DuoTrav ™ 2,5 ml of eye drops
MEDOPTIKA (Kazakhstan)
Neomycin + Dexamethasone Eye, Ear and Nose Drops (5 ml)
Lecos (Kazakhstan)
Taufon® (Taurine) Eye Drops 4%, 15 ml
Alcon (Spain)
Sisteyn Balance 10ml lubricant eye drops